Featured ArticlesLatest NewsOncodermatologySkin of ColorSkincare

Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients

By August 12, 2026No Comments

Advancing Oncodermatology: The New LACOM II Algorithm for Cutaneous Adverse Events 

Have you checked out this crucial publication in the latest edition of the JDD?

Cutaneous adverse events arising from modern anticancer therapies present a complex, daily management challenge for clinicians. Beyond causing physical discomfort, these skin toxicities frequently compromise patient quality of life and can even lead to necessary, yet detrimental, cancer treatment interruptions or dose reductions. To help clinicians proactively navigate these toxicities, an interdisciplinary panel of experts developed the updated LACOM II algorithm, offering a structured framework for preventing and managing treatment-related cutaneous reactions across the full continuum of cancer care.

The collaborative panel, comprising dermatologists, clinical oncologists, and radiation oncologists, established this evidence-based consensus to bridge care gaps between specialty disciplines. The protocol focuses on practical, low-risk interventions including targeted hygiene, barrier-restoring moisturization, strict photoprotection, and specialized camouflage solutions to support overall skin integrity during active oncology treatments.

Key elements of the algorithm address the critical window before therapy commences, emphasizing the proactive role of clinician-led patient education. The guidance outlines standardized triage pathways, early symptom identification methods, and reaction-specific intervention strategies. Furthermore, the consensus underscores the measurable impact that coordinated, multidisciplinary care teams have on minimizing treatment delays and preserving patient well-being.
As cancer therapeutics evolve, having a standardized, evidence-based approach to supportive dermatologic care is vital for optimizing clinical management and enhancing patient comfort throughout therapy.

Visit the Journal of Drugs in Dermatology to access the complete LACOM II clinical algorithm, review the detailed treatment recommendations, and integrate these expert consensus guidelines into your practice.

Blog write-up assisted by AI